Get Bullish: 3 Next-Generation Defence Stocks
Here is the latest financial fact sheet of OMKAR PHARMACHEM. For more details, see the OMKAR PHARMACHEM quarterly results and OMKAR PHARMACHEM share price.
1 Day | % | 2.1 |
No. of shares | m | 10.08 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 24.5/18.9 |
No. of Mths Year Ending |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
5-Yr Chart Click to enlarge
|
---|
OMKAR PHARMACHEM EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 7 | 10 | 13 | 16 | 21 | |
Low | Rs | 6 | 7 | 10 | 13 | 16 | |
Sales per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.3 | |
Earnings per share (Unadj.) | Rs | 0.2 | -0.3 | -0.4 | -0.3 | 0.2 | |
Diluted earnings per share | Rs | 0.2 | -0.3 | -0.4 | -0.3 | 0.2 | |
Cash flow per share (Unadj.) | Rs | 0.2 | -0.3 | -0.4 | -0.3 | 0.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 9.3 | 9.0 | 8.6 | 8.4 | 8.6 | |
Adj. book value per share | Rs | 9.3 | 9.0 | 8.6 | 8.4 | 8.6 | |
Shares outstanding (eoy) | m | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | |
Price / Sales ratio | x | 0 | 0 | 0 | 330.6 | 68.4 | |
Avg P/E ratio | x | 29.8 | -33.9 | -27.0 | -57.3 | 83.3 | |
P/CF ratio (eoy) | x | 29.5 | -34.2 | -27.2 | -57.7 | 82.9 | |
Price / Book Value ratio | x | 0.7 | 1.0 | 1.3 | 1.8 | 2.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 66 | 87 | 113 | 149 | 185 | |
Total wages/salary | Rs m | 1 | 1 | 2 | 2 | 1 |
OMKAR PHARMACHEM INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | 0 | 0 | 3 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 0 | 0 | 0 | 0 | 3 | |
Gross profit | Rs m | 3 | -2 | -4 | -2 | 0 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 1 | 1 | |
Profit before tax | Rs m | 3 | -3 | -4 | -3 | 0 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | -3 | |
Profit after tax | Rs m | 2 | -3 | -4 | -3 | 2 | |
Gross profit margin | % | 0 | 0 | 0 | -454.2 | 8.1 | |
Effective tax rate | % | 18.2 | -1.2 | 0.1 | 0 | 714.7 | |
Net profit margin | % | 0 | 0 | 0 | -576.9 | 82.0 |
OMKAR PHARMACHEM BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1 | 1 | 0 | 1 | 1 | |
Current liabilities | Rs m | 1 | 3 | 6 | 9 | 10 | |
Net working cap to sales | % | 0 | 0 | 0 | -1,915.1 | -332.1 | |
Current ratio | x | 2.3 | 0.3 | 0 | 0.1 | 0.1 | |
Inventory Days | Days | 0 | 0 | 0 | 75,433 | 12,572 | |
Debtors Days | Days | 0 | 0 | 0 | 1,460 | 365 | |
Net fixed assets | Rs m | 93 | 93 | 93 | 93 | 93 | |
Share capital | Rs m | 101 | 101 | 101 | 101 | 101 | |
"Free" reserves | Rs m | -7 | -10 | -14 | -16 | -14 | |
Net worth | Rs m | 94 | 91 | 87 | 84 | 87 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 94 | 94 | 93 | 94 | 94 | |
Interest coverage | x | 0 | -17.1 | -10.4 | -3.9 | 0.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0 | 0 | 0 | 0 | 0 | |
Return on assets | % | 2.3 | -2.6 | -4.1 | -2.2 | 3.0 | |
Return on equity | % | 2.4 | -2.8 | -4.8 | -3.1 | 2.6 | |
Return on capital | % | 2.9 | -2.6 | -4.4 | -2.4 | 0.2 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
OMKAR PHARMACHEM CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -8 | -3 | -3 | -2 | 0 | |
From Investments | Rs m | 5 | -0 | 0 | -0 | 0 | |
From Financial Activity | Rs m | 0 | 2 | 3 | 2 | -0 | |
Net Cashflow | Rs m | -3 | -0 | 0 | 0 | 0 |
Share Holding
Shareholding as on Jun 2022
|
Company Information
|
CHM: Bhawani Shankar Goyal | COMP SEC: Pankaj Singh | YEAR OF INC: 1995 | BSE CODE: 532167 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: UPL PIDILITE INDUSTRIES KAVERI SEED DEEPAK NITRITE AARTI INDUSTRIES
Compare OMKAR PHARMACHEM With: UPL PIDILITE INDUSTRIES KAVERI SEED DEEPAK NITRITE AARTI INDUSTRIES
After opening the day on a flat note, Indian share markets extended gains as the session progressed and ended near day's high.